These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Therapeutic effect of ceftizoxime on infection in patients with lung cancer].
    Author: Hiraki S, Ohnoshi T, Tamura M, Kawahara S, Miyamoto H, Nishii K, Kimura I.
    Journal: Jpn J Antibiot; 1986 Jan; 39(1):87-93. PubMed ID: 3009911.
    Abstract:
    Ceftizoxime (CZX) was given in daily doses of 4 approximately 6 g by intravenous drip infusion to 30 patients with infection accompanying lung cancer to investigate the usefulness of the drug for infectious disease: The rate of effectiveness (marked and moderate) was 73.3% (22/30 patients). Of the 30 patients, 2 had drug fever; 1, arthralgia; and 1, eosinophilia. These side effects improved after the drug was withdrawn. CZX is a very useful antibiotic with high effectiveness and safety in immunocompromised patients with infection accompanying advanced lung cancer.
    [Abstract] [Full Text] [Related] [New Search]